Brett Kaplan

Insider Reports History

Location
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY
Signature
/s/ Emily Pimblett, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brett Kaplan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. Chief Operating Officer Restricted Stock Units 77.5K $618K $7.98 Aug 26, 2024 Direct
Climb Bio, Inc. Chief Operating Officer Stock Option (Right to Buy) 500K Jan 13, 2025 Direct
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 30K Feb 18, 2022 Direct

Insider Reports Filed by Brett Kaplan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLYM Climb Bio, Inc. Jan 13, 2025 1 $0 4 Jan 15, 2025 Chief Operating Officer
ELYM Eliem Therapeutics, Inc. Aug 26, 2024 2 $0 4 Aug 26, 2024 Chief Operating Officer
ELYM Eliem Therapeutics, Inc. Aug 26, 2024 0 $0 3 Aug 26, 2024 Chief Operating Officer
CMPX Compass Therapeutics, Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 Director